Cargando…
Cardiac MRI findings to differentiate athlete's heart from hypertrophic (HCM), arrhythmogenic right ventricular (ARVC) and dilated (DCM) cardiomyopathy
To provide clinically relevant criteria for differentiation between the athlete’s heart and similar appearing hypertrophic (HCM), dilated (DCM), and arrhythmogenic right-ventricular cardiomyopathy (ARVC) in MRI. 40 top-level athletes were prospectively examined with cardiac MR (CMR) in two universit...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302518/ https://www.ncbi.nlm.nih.gov/pubmed/34019206 http://dx.doi.org/10.1007/s10554-021-02280-6 |
_version_ | 1783726896257695744 |
---|---|
author | Kübler, J. Burgstahler, C. Brendel, J. M. Gassenmaier, S. Hagen, F. Klingel, K. Olthof, S.-C. Blume, K. Wolfarth, B. Mueller, K. A. L. Greulich, S. Krumm, P. |
author_facet | Kübler, J. Burgstahler, C. Brendel, J. M. Gassenmaier, S. Hagen, F. Klingel, K. Olthof, S.-C. Blume, K. Wolfarth, B. Mueller, K. A. L. Greulich, S. Krumm, P. |
author_sort | Kübler, J. |
collection | PubMed |
description | To provide clinically relevant criteria for differentiation between the athlete’s heart and similar appearing hypertrophic (HCM), dilated (DCM), and arrhythmogenic right-ventricular cardiomyopathy (ARVC) in MRI. 40 top-level athletes were prospectively examined with cardiac MR (CMR) in two university centres and compared to retrospectively recruited patients diagnosed with HCM (n = 14), ARVC (n = 18), and DCM (n = 48). Analysed MR imaging parameters in the whole study cohort included morphology, functional parameters and late gadolinium enhancement (LGE). Mean left-ventricular enddiastolic volume index (LVEDVI) was high in athletes (105 ml/m(2)) but significantly lower compared to DCM (132 ml/m(2); p = 0.001). Mean LV ejection fraction (EF) was 61% in athletes, below normal in 7 (18%) athletes vs. EF 29% in DCM, below normal in 46 (96%) patients (p < 0.0001). Mean RV-EF was 54% in athletes vs. 60% in HCM, 46% in ARVC, and 41% in DCM (p < 0.0001). Mean interventricular myocardial thickness was 10 mm in athletes vs. 12 mm in HCM (p = 0.0005), 9 mm in ARVC, and 9 mm in DCM. LGE was present in 1 (5%) athlete, 8 (57%) HCM, 10 (56%) ARVC, and 21 (44%) DCM patients (p < 0.0001). Healthy athletes’ hearts are characterized by both hypertrophy and dilation, low EF of both ventricles at rest, and increased interventricular septal thickness with a low prevalence of LGE. Differentiation of athlete’s heart from other non-ischemic cardiomyopathies in MRI can be challenging due to a significant overlap of characteristics also seen in HCM, ARVC, and DCM. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10554-021-02280-6. |
format | Online Article Text |
id | pubmed-8302518 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-83025182021-07-27 Cardiac MRI findings to differentiate athlete's heart from hypertrophic (HCM), arrhythmogenic right ventricular (ARVC) and dilated (DCM) cardiomyopathy Kübler, J. Burgstahler, C. Brendel, J. M. Gassenmaier, S. Hagen, F. Klingel, K. Olthof, S.-C. Blume, K. Wolfarth, B. Mueller, K. A. L. Greulich, S. Krumm, P. Int J Cardiovasc Imaging Original Paper To provide clinically relevant criteria for differentiation between the athlete’s heart and similar appearing hypertrophic (HCM), dilated (DCM), and arrhythmogenic right-ventricular cardiomyopathy (ARVC) in MRI. 40 top-level athletes were prospectively examined with cardiac MR (CMR) in two university centres and compared to retrospectively recruited patients diagnosed with HCM (n = 14), ARVC (n = 18), and DCM (n = 48). Analysed MR imaging parameters in the whole study cohort included morphology, functional parameters and late gadolinium enhancement (LGE). Mean left-ventricular enddiastolic volume index (LVEDVI) was high in athletes (105 ml/m(2)) but significantly lower compared to DCM (132 ml/m(2); p = 0.001). Mean LV ejection fraction (EF) was 61% in athletes, below normal in 7 (18%) athletes vs. EF 29% in DCM, below normal in 46 (96%) patients (p < 0.0001). Mean RV-EF was 54% in athletes vs. 60% in HCM, 46% in ARVC, and 41% in DCM (p < 0.0001). Mean interventricular myocardial thickness was 10 mm in athletes vs. 12 mm in HCM (p = 0.0005), 9 mm in ARVC, and 9 mm in DCM. LGE was present in 1 (5%) athlete, 8 (57%) HCM, 10 (56%) ARVC, and 21 (44%) DCM patients (p < 0.0001). Healthy athletes’ hearts are characterized by both hypertrophy and dilation, low EF of both ventricles at rest, and increased interventricular septal thickness with a low prevalence of LGE. Differentiation of athlete’s heart from other non-ischemic cardiomyopathies in MRI can be challenging due to a significant overlap of characteristics also seen in HCM, ARVC, and DCM. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10554-021-02280-6. Springer Netherlands 2021-05-21 2021 /pmc/articles/PMC8302518/ /pubmed/34019206 http://dx.doi.org/10.1007/s10554-021-02280-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Paper Kübler, J. Burgstahler, C. Brendel, J. M. Gassenmaier, S. Hagen, F. Klingel, K. Olthof, S.-C. Blume, K. Wolfarth, B. Mueller, K. A. L. Greulich, S. Krumm, P. Cardiac MRI findings to differentiate athlete's heart from hypertrophic (HCM), arrhythmogenic right ventricular (ARVC) and dilated (DCM) cardiomyopathy |
title | Cardiac MRI findings to differentiate athlete's heart from hypertrophic (HCM), arrhythmogenic right ventricular (ARVC) and dilated (DCM) cardiomyopathy |
title_full | Cardiac MRI findings to differentiate athlete's heart from hypertrophic (HCM), arrhythmogenic right ventricular (ARVC) and dilated (DCM) cardiomyopathy |
title_fullStr | Cardiac MRI findings to differentiate athlete's heart from hypertrophic (HCM), arrhythmogenic right ventricular (ARVC) and dilated (DCM) cardiomyopathy |
title_full_unstemmed | Cardiac MRI findings to differentiate athlete's heart from hypertrophic (HCM), arrhythmogenic right ventricular (ARVC) and dilated (DCM) cardiomyopathy |
title_short | Cardiac MRI findings to differentiate athlete's heart from hypertrophic (HCM), arrhythmogenic right ventricular (ARVC) and dilated (DCM) cardiomyopathy |
title_sort | cardiac mri findings to differentiate athlete's heart from hypertrophic (hcm), arrhythmogenic right ventricular (arvc) and dilated (dcm) cardiomyopathy |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302518/ https://www.ncbi.nlm.nih.gov/pubmed/34019206 http://dx.doi.org/10.1007/s10554-021-02280-6 |
work_keys_str_mv | AT kublerj cardiacmrifindingstodifferentiateathletesheartfromhypertrophichcmarrhythmogenicrightventriculararvcanddilateddcmcardiomyopathy AT burgstahlerc cardiacmrifindingstodifferentiateathletesheartfromhypertrophichcmarrhythmogenicrightventriculararvcanddilateddcmcardiomyopathy AT brendeljm cardiacmrifindingstodifferentiateathletesheartfromhypertrophichcmarrhythmogenicrightventriculararvcanddilateddcmcardiomyopathy AT gassenmaiers cardiacmrifindingstodifferentiateathletesheartfromhypertrophichcmarrhythmogenicrightventriculararvcanddilateddcmcardiomyopathy AT hagenf cardiacmrifindingstodifferentiateathletesheartfromhypertrophichcmarrhythmogenicrightventriculararvcanddilateddcmcardiomyopathy AT klingelk cardiacmrifindingstodifferentiateathletesheartfromhypertrophichcmarrhythmogenicrightventriculararvcanddilateddcmcardiomyopathy AT olthofsc cardiacmrifindingstodifferentiateathletesheartfromhypertrophichcmarrhythmogenicrightventriculararvcanddilateddcmcardiomyopathy AT blumek cardiacmrifindingstodifferentiateathletesheartfromhypertrophichcmarrhythmogenicrightventriculararvcanddilateddcmcardiomyopathy AT wolfarthb cardiacmrifindingstodifferentiateathletesheartfromhypertrophichcmarrhythmogenicrightventriculararvcanddilateddcmcardiomyopathy AT muellerkal cardiacmrifindingstodifferentiateathletesheartfromhypertrophichcmarrhythmogenicrightventriculararvcanddilateddcmcardiomyopathy AT greulichs cardiacmrifindingstodifferentiateathletesheartfromhypertrophichcmarrhythmogenicrightventriculararvcanddilateddcmcardiomyopathy AT krummp cardiacmrifindingstodifferentiateathletesheartfromhypertrophichcmarrhythmogenicrightventriculararvcanddilateddcmcardiomyopathy |